Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:8:1377-83.
doi: 10.2147/IJN.S37788. Epub 2013 Apr 12.

Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid

Affiliations

Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid

Wei Wang et al. Int J Nanomedicine. 2013.

Abstract

Glycyrrhizic acid (GA), the main component of radix glycyrrhizae, has a variety of pharmacological activities. In the present study, suspensions of GA nanoparticles with the average particle size about 200 nm were prepared by a supercritical antisolvent (SAS) process. Comparative studies were undertaken using lipopolysaccardide (LPS)-stimulated mouse macrophages RAW 264.7 as in vitro inflammatory model. Several important inflammation mediators such as NO, PGE2, TNF-α and IL-6 were examined. These markers were highly stimulated by LPS and were inhibited both by nano-GA and unprocessed GA in a dose-dependent manner, especially PGE2 and TNF-α. However nano-GA and unprocessed GA inhibited NO only at a high concentration. In general, we found that GA nanoparticle suspensions exhibited much better anti-inflammatory activities compared to unprocessed GA.

Keywords: glycyrrhizic acid; inflammatory cytokines; mouse macrophages RAW 264.7; nanoparticle.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scanning electron microscopy result of (A) unprocessed GA and (B) GA nanoparticles. Abbreviation: GA, glycyrrhizic acid.
Figure 2
Figure 2
Effect of different concentrations of GA nanoparticles and unprocessed GA on LPS-induced nitric oxide. Note: *P < 0.05, significantly different from the LPS-treated group by unpaired Student’s t-test. Abbreviations: GA, glycyrrhizic acid; LPS, lipopolysaccharide.
Figure 3
Figure 3
Effect of different concentrations of GA nanoparticles and unprocessed GA on LPS-induced PGE2. Notes: *P < 0.05; **P < 0.01, significantly different from the LPS-treated group by unpaired Student’s t-test. Abbreviations: GA, glycyrrhizic acid; LPS, lipopolysaccharide; PGE2, prostaglandin E2.
Figure 4
Figure 4
Effect of different concentrations of GA nanoparticles and unprocessed GA on LPS-induced TNF-α. Notes: *P < 0.05; **P < 0.01, significantly different from the LPS-treated group by unpaired Student’s t-test. Abbreviations: GA, glycyrrhizic acid; LPS, lipopolysaccharide; TNF-α, tumor necrosis factor-α.
Figure 5
Figure 5
Effect of different concentrations of GA nanoparticles and unprocessed GA on LPS-induced IL-6. Note: **P < 0.01, significantly different from the LPS-treated group by unpaired Student’s t-test. Abbreviations: GA, glycyrrhizic acid; LPS, lipopolysaccharide;IL-6, interleukin-6.

Similar articles

Cited by

References

    1. Shin EM, Zhou HY, Guo LY, et al. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol. 2008;8(11):1524–1532. - PubMed
    1. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995;35:655–677. - PubMed
    1. Park YD, Jin CH, Choi DS, Byun MW, Jeong IY. Biological evaluation of isoegomaketone isolated from Perilla frutescens and its synthetic derivatives as anti-inflammatory agents. Arch Pharm Res. 2011;34(8):1277–1282. - PubMed
    1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6(12):3051–3064. - PubMed
    1. O’Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov. 2006;5(7):549–563. - PubMed

Publication types

LinkOut - more resources